The Latest Breaking News from Medicare

WASHINGTON — The deal between Speaker Kevin McCarthy and his conservative detractors lays a foundation for the massive spending cuts that some want, but also sets up a daunting challenge for GOP lawmakers who want to keep the government functioning after winning control of the House.

The House Republican deal lays a foundation for the spending cuts that some want, but also a challenge to keep the government functioning.

By simply giving more cash to selected programs, we deflect attention away from smart, system-wide reforms that would help those who need it most

WASHINGTON — A conservative Republican at the center of the tortured effort to elect House Speaker Kevin McCarthy says he’d welcome a hard-fought battle over the U.S. debt ceiling, but said both parties should start negotiating terms for the increase now so it doesn’t go down to the wire.

WASHINGTON — A conservative Republican at the center of the tortured effort to elect House Speaker Kevin McCarthy says he’d welcome a hard-fought battle over the U.S. debt ceiling, but said both parties should start negotiating terms for the increase now so it doesn’t go down to the wire.

Canberra's bulk-billing rate is 40 per cent below the national average.

An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.

Gladstone residents are "shocked" by the sudden closure of their local GP practice but doctors warn it won't be the last, while calling on the federal government to take "urgent measures".

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

Biogen stock jumped late Friday after the Food and Drug Administration approved its second Alzheimer's treatment, now called Leqembi.